COVID-19 Impact on Global Renal Anemia Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 94 pages | ID: CD812A6D39BBEN
QYResearch

Abstracts

This report focuses on the global Renal Anemia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Renal Anemia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bayer AG
• BIOCAD
• CCM Duopharma Biotech Bhd.
• Chong Kun Dang Pharmaceutical Corp.
• Daiichi Sankyo Company, Limited
• Dong-A Socio Group
• Dr. Reddy's Laboratories Limited
• Eli Lilly and Company
• FibroGen, Inc.
• GlaxoSmithKline Plc
• Intas Pharmaceuticals Ltd.
• Japan Tobacco Inc.
• JCR Pharmaceuticals Co., Ltd.
• Jiangsu Hansoh Pharmaceutical Co., Ltd.

Market segment by Type, the product can be split into

• DS-1093
• EPO-018B
• FG-2216
• JTZ-951
• MDGN-201
• MMP-0101
• Others

Market segment by Application, split into

• Hospital
• Research Center
• Clinic

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Renal Anemia Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Renal Anemia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Renal Anemia Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Renal Anemia Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Renal Anemia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 DS-1093
  1.4.3 EPO-018B
  1.4.4 FG-2216
  1.4.5 JTZ-951
  1.4.6 MDGN-201
  1.4.7 MMP-0101
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Renal Anemia Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Research Center
  1.5.4 Clinic
1.6 Coronavirus Disease 2019 (Covid-19): Renal Anemia Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Renal Anemia Therapeutics Industry
    1.6.1.1 Renal Anemia Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Renal Anemia Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Renal Anemia Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Renal Anemia Therapeutics Market Perspective (2015-2026)
2.2 Renal Anemia Therapeutics Growth Trends by Regions
  2.2.1 Renal Anemia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Renal Anemia Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Renal Anemia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Renal Anemia Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Renal Anemia Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Renal Anemia Therapeutics Players by Market Size
  3.1.1 Global Top Renal Anemia Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Renal Anemia Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Renal Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Renal Anemia Therapeutics Market Concentration Ratio
  3.2.1 Global Renal Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Renal Anemia Therapeutics Revenue in 2019
3.3 Renal Anemia Therapeutics Key Players Head office and Area Served
3.4 Key Players Renal Anemia Therapeutics Product Solution and Service
3.5 Date of Enter into Renal Anemia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Renal Anemia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Renal Anemia Therapeutics Forecasted Market Size by Type (2021-2026)

5 RENAL ANEMIA THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Renal Anemia Therapeutics Market Size by Application (2015-2020)
5.2 Global Renal Anemia Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Renal Anemia Therapeutics Market Size (2015-2020)
6.2 Renal Anemia Therapeutics Key Players in North America (2019-2020)
6.3 North America Renal Anemia Therapeutics Market Size by Type (2015-2020)
6.4 North America Renal Anemia Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Renal Anemia Therapeutics Market Size (2015-2020)
7.2 Renal Anemia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Renal Anemia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Renal Anemia Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Renal Anemia Therapeutics Market Size (2015-2020)
8.2 Renal Anemia Therapeutics Key Players in China (2019-2020)
8.3 China Renal Anemia Therapeutics Market Size by Type (2015-2020)
8.4 China Renal Anemia Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Renal Anemia Therapeutics Market Size (2015-2020)
9.2 Renal Anemia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Renal Anemia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Renal Anemia Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Renal Anemia Therapeutics Market Size (2015-2020)
10.2 Renal Anemia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Renal Anemia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Renal Anemia Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Renal Anemia Therapeutics Market Size (2015-2020)
11.2 Renal Anemia Therapeutics Key Players in India (2019-2020)
11.3 India Renal Anemia Therapeutics Market Size by Type (2015-2020)
11.4 India Renal Anemia Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Renal Anemia Therapeutics Market Size (2015-2020)
12.2 Renal Anemia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Renal Anemia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Renal Anemia Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bayer AG
  13.1.1 Bayer AG Company Details
  13.1.2 Bayer AG Business Overview and Its Total Revenue
  13.1.3 Bayer AG Renal Anemia Therapeutics Introduction
  13.1.4 Bayer AG Revenue in Renal Anemia Therapeutics Business (2015-2020))
  13.1.5 Bayer AG Recent Development
13.2 BIOCAD
  13.2.1 BIOCAD Company Details
  13.2.2 BIOCAD Business Overview and Its Total Revenue
  13.2.3 BIOCAD Renal Anemia Therapeutics Introduction
  13.2.4 BIOCAD Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.2.5 BIOCAD Recent Development
13.3 CCM Duopharma Biotech Bhd.
  13.3.1 CCM Duopharma Biotech Bhd. Company Details
  13.3.2 CCM Duopharma Biotech Bhd. Business Overview and Its Total Revenue
  13.3.3 CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Introduction
  13.3.4 CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.3.5 CCM Duopharma Biotech Bhd. Recent Development
13.4 Chong Kun Dang Pharmaceutical Corp.
  13.4.1 Chong Kun Dang Pharmaceutical Corp. Company Details
  13.4.2 Chong Kun Dang Pharmaceutical Corp. Business Overview and Its Total Revenue
  13.4.3 Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Introduction
  13.4.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.4.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
13.5 Daiichi Sankyo Company, Limited
  13.5.1 Daiichi Sankyo Company, Limited Company Details
  13.5.2 Daiichi Sankyo Company, Limited Business Overview and Its Total Revenue
  13.5.3 Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Introduction
  13.5.4 Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.5.5 Daiichi Sankyo Company, Limited Recent Development
13.6 Dong-A Socio Group
  13.6.1 Dong-A Socio Group Company Details
  13.6.2 Dong-A Socio Group Business Overview and Its Total Revenue
  13.6.3 Dong-A Socio Group Renal Anemia Therapeutics Introduction
  13.6.4 Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.6.5 Dong-A Socio Group Recent Development
13.7 Dr. Reddy's Laboratories Limited
  13.7.1 Dr. Reddy's Laboratories Limited Company Details
  13.7.2 Dr. Reddy's Laboratories Limited Business Overview and Its Total Revenue
  13.7.3 Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Introduction
  13.7.4 Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.7.5 Dr. Reddy's Laboratories Limited Recent Development
13.8 Eli Lilly and Company
  13.8.1 Eli Lilly and Company Company Details
  13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.8.3 Eli Lilly and Company Renal Anemia Therapeutics Introduction
  13.8.4 Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.8.5 Eli Lilly and Company Recent Development
13.9 FibroGen, Inc.
  13.9.1 FibroGen, Inc. Company Details
  13.9.2 FibroGen, Inc. Business Overview and Its Total Revenue
  13.9.3 FibroGen, Inc. Renal Anemia Therapeutics Introduction
  13.9.4 FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.9.5 FibroGen, Inc. Recent Development
13.10 GlaxoSmithKline Plc
  13.10.1 GlaxoSmithKline Plc Company Details
  13.10.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  13.10.3 GlaxoSmithKline Plc Renal Anemia Therapeutics Introduction
  13.10.4 GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2015-2020)
  13.10.5 GlaxoSmithKline Plc Recent Development
13.11 Intas Pharmaceuticals Ltd.
  10.11.1 Intas Pharmaceuticals Ltd. Company Details
  10.11.2 Intas Pharmaceuticals Ltd. Business Overview and Its Total Revenue
  10.11.3 Intas Pharmaceuticals Ltd. Renal Anemia Therapeutics Introduction
  10.11.4 Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2015-2020)
  10.11.5 Intas Pharmaceuticals Ltd. Recent Development
13.12 Japan Tobacco Inc.
  10.12.1 Japan Tobacco Inc. Company Details
  10.12.2 Japan Tobacco Inc. Business Overview and Its Total Revenue
  10.12.3 Japan Tobacco Inc. Renal Anemia Therapeutics Introduction
  10.12.4 Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2015-2020)
  10.12.5 Japan Tobacco Inc. Recent Development
13.13 JCR Pharmaceuticals Co., Ltd.
  10.13.1 JCR Pharmaceuticals Co., Ltd. Company Details
  10.13.2 JCR Pharmaceuticals Co., Ltd. Business Overview and Its Total Revenue
  10.13.3 JCR Pharmaceuticals Co., Ltd. Renal Anemia Therapeutics Introduction
  10.13.4 JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2015-2020)
  10.13.5 JCR Pharmaceuticals Co., Ltd. Recent Development
13.14 Jiangsu Hansoh Pharmaceutical Co., Ltd.
  10.14.1 Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Details
  10.14.2 Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
  10.14.3 Jiangsu Hansoh Pharmaceutical Co., Ltd. Renal Anemia Therapeutics Introduction
  10.14.4 Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2015-2020)
  10.14.5 Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Renal Anemia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Renal Anemia Therapeutics Revenue
Table 3. Ranking of Global Top Renal Anemia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Renal Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DS-1093
Table 6. Key Players of EPO-018B
Table 7. Key Players of FG-2216
Table 8. Key Players of JTZ-951
Table 9. Key Players of MDGN-201
Table 10. Key Players of MMP-0101
Table 11. Key Players of Others
Table 12. COVID-19 Impact Global Market: (Four Renal Anemia Therapeutics Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Renal Anemia Therapeutics Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Renal Anemia Therapeutics Players to Combat Covid-19 Impact
Table 17. Global Renal Anemia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Renal Anemia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Renal Anemia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Renal Anemia Therapeutics Market Share by Regions (2015-2020)
Table 21. Global Renal Anemia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Renal Anemia Therapeutics Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Renal Anemia Therapeutics Market Growth Strategy
Table 27. Main Points Interviewed from Key Renal Anemia Therapeutics Players
Table 28. Global Renal Anemia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 29. Global Renal Anemia Therapeutics Market Share by Players (2015-2020)
Table 30. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Anemia Therapeutics as of 2019)
Table 31. Global Renal Anemia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Renal Anemia Therapeutics Product Solution and Service
Table 34. Date of Enter into Renal Anemia Therapeutics Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. Global Renal Anemia Therapeutics Market Size Share by Type (2015-2020)
Table 38. Global Renal Anemia Therapeutics Revenue Market Share by Type (2021-2026)
Table 39. Global Renal Anemia Therapeutics Market Size Share by Application (2015-2020)
Table 40. Global Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. Global Renal Anemia Therapeutics Market Size Share by Application (2021-2026)
Table 42. North America Key Players Renal Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Renal Anemia Therapeutics Market Share (2019-2020)
Table 44. North America Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. North America Renal Anemia Therapeutics Market Share by Type (2015-2020)
Table 46. North America Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. North America Renal Anemia Therapeutics Market Share by Application (2015-2020)
Table 48. Europe Key Players Renal Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Renal Anemia Therapeutics Market Share (2019-2020)
Table 50. Europe Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Renal Anemia Therapeutics Market Share by Type (2015-2020)
Table 52. Europe Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Renal Anemia Therapeutics Market Share by Application (2015-2020)
Table 54. China Key Players Renal Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 55. China Key Players Renal Anemia Therapeutics Market Share (2019-2020)
Table 56. China Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. China Renal Anemia Therapeutics Market Share by Type (2015-2020)
Table 58. China Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. China Renal Anemia Therapeutics Market Share by Application (2015-2020)
Table 60. Japan Key Players Renal Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Renal Anemia Therapeutics Market Share (2019-2020)
Table 62. Japan Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Renal Anemia Therapeutics Market Share by Type (2015-2020)
Table 64. Japan Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Renal Anemia Therapeutics Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Renal Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Renal Anemia Therapeutics Market Share (2019-2020)
Table 68. Southeast Asia Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Renal Anemia Therapeutics Market Share by Type (2015-2020)
Table 70. Southeast Asia Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Renal Anemia Therapeutics Market Share by Application (2015-2020)
Table 72. India Key Players Renal Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 73. India Key Players Renal Anemia Therapeutics Market Share (2019-2020)
Table 74. India Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. India Renal Anemia Therapeutics Market Share by Type (2015-2020)
Table 76. India Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. India Renal Anemia Therapeutics Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Renal Anemia Therapeutics Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Renal Anemia Therapeutics Market Share (2019-2020)
Table 80. Central & South America Renal Anemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Renal Anemia Therapeutics Market Share by Type (2015-2020)
Table 82. Central & South America Renal Anemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Renal Anemia Therapeutics Market Share by Application (2015-2020)
Table 84. Bayer AG Company Details
Table 85. Bayer AG Business Overview
Table 86. Bayer AG Product
Table 87. Bayer AG Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 88. Bayer AG Recent Development
Table 89. BIOCAD Company Details
Table 90. BIOCAD Business Overview
Table 91. BIOCAD Product
Table 92. BIOCAD Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 93. BIOCAD Recent Development
Table 94. CCM Duopharma Biotech Bhd. Company Details
Table 95. CCM Duopharma Biotech Bhd. Business Overview
Table 96. CCM Duopharma Biotech Bhd. Product
Table 97. CCM Duopharma Biotech Bhd. Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 98. CCM Duopharma Biotech Bhd. Recent Development
Table 99. Chong Kun Dang Pharmaceutical Corp. Company Details
Table 100. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 101. Chong Kun Dang Pharmaceutical Corp. Product
Table 102. Chong Kun Dang Pharmaceutical Corp. Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 103. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 104. Daiichi Sankyo Company, Limited Company Details
Table 105. Daiichi Sankyo Company, Limited Business Overview
Table 106. Daiichi Sankyo Company, Limited Product
Table 107. Daiichi Sankyo Company, Limited Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 108. Daiichi Sankyo Company, Limited Recent Development
Table 109. Dong-A Socio Group Company Details
Table 110. Dong-A Socio Group Business Overview
Table 111. Dong-A Socio Group Product
Table 112. Dong-A Socio Group Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 113. Dong-A Socio Group Recent Development
Table 114. Dr. Reddy's Laboratories Limited Company Details
Table 115. Dr. Reddy's Laboratories Limited Business Overview
Table 116. Dr. Reddy's Laboratories Limited Product
Table 117. Dr. Reddy's Laboratories Limited Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 118. Dr. Reddy's Laboratories Limited Recent Development
Table 119. Eli Lilly and Company Business Overview
Table 120. Eli Lilly and Company Product
Table 121. Eli Lilly and Company Company Details
Table 122. Eli Lilly and Company Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 123. Eli Lilly and Company Recent Development
Table 124. FibroGen, Inc. Company Details
Table 125. FibroGen, Inc. Business Overview
Table 126. FibroGen, Inc. Product
Table 127. FibroGen, Inc. Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 128. FibroGen, Inc. Recent Development
Table 129. GlaxoSmithKline Plc Company Details
Table 130. GlaxoSmithKline Plc Business Overview
Table 131. GlaxoSmithKline Plc Product
Table 132. GlaxoSmithKline Plc Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 133. GlaxoSmithKline Plc Recent Development
Table 134. Intas Pharmaceuticals Ltd. Company Details
Table 135. Intas Pharmaceuticals Ltd. Business Overview
Table 136. Intas Pharmaceuticals Ltd. Product
Table 137. Intas Pharmaceuticals Ltd. Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 138. Intas Pharmaceuticals Ltd. Recent Development
Table 139. Japan Tobacco Inc. Company Details
Table 140. Japan Tobacco Inc. Business Overview
Table 141. Japan Tobacco Inc. Product
Table 142. Japan Tobacco Inc. Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 143. Japan Tobacco Inc. Recent Development
Table 144. JCR Pharmaceuticals Co., Ltd. Company Details
Table 145. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 146. JCR Pharmaceuticals Co., Ltd. Product
Table 147. JCR Pharmaceuticals Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 148. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 149. Jiangsu Hansoh Pharmaceutical Co., Ltd. Company Details
Table 150. Jiangsu Hansoh Pharmaceutical Co., Ltd. Business Overview
Table 151. Jiangsu Hansoh Pharmaceutical Co., Ltd. Product
Table 152. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue in Renal Anemia Therapeutics Business (2015-2020) (Million US$)
Table 153. Jiangsu Hansoh Pharmaceutical Co., Ltd. Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Renal Anemia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. DS-1093 Features
Figure 3. EPO-018B Features
Figure 4. FG-2216 Features
Figure 5. JTZ-951 Features
Figure 6. MDGN-201 Features
Figure 7. MMP-0101 Features
Figure 8. Others Features
Figure 9. Global Renal Anemia Therapeutics Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Research Center Case Studies
Figure 12. Clinic Case Studies
Figure 13. Renal Anemia Therapeutics Report Years Considered
Figure 14. Global Renal Anemia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Renal Anemia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 16. Global Renal Anemia Therapeutics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Renal Anemia Therapeutics Market Share by Players in 2019
Figure 19. Global Top Renal Anemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Anemia Therapeutics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Renal Anemia Therapeutics Revenue in 2019
Figure 21. North America Renal Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Renal Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Renal Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Renal Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Renal Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Renal Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Renal Anemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bayer AG Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 30. BIOCAD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. BIOCAD Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 32. CCM Duopharma Biotech Bhd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. CCM Duopharma Biotech Bhd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 34. Chong Kun Dang Pharmaceutical Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 36. Daiichi Sankyo Company, Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Daiichi Sankyo Company, Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 38. Dong-A Socio Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Dong-A Socio Group Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 40. Dr. Reddy's Laboratories Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Dr. Reddy's Laboratories Limited Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 42. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Eli Lilly and Company Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 44. FibroGen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. FibroGen, Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 46. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. GlaxoSmithKline Plc Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 48. Intas Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 50. Japan Tobacco Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Japan Tobacco Inc. Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 52. JCR Pharmaceuticals Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 54. Jiangsu Hansoh Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Jiangsu Hansoh Pharmaceutical Co., Ltd. Revenue Growth Rate in Renal Anemia Therapeutics Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed